Value of PET imaging for radiation therapy.

Authors :: Lapa C
Nestle U
Albert NL
Baues C
Beer A
Buck A
Budach V
Bütof R
Combs SE
Derlin T
Eiber M
Fendler WP
Furth C
Gani C
Gkika E
Grosu AL
Henkenberens C
Ilhan H
Löck S
Marnitz-Schulze S
Miederer M
Mix M
Nicolay NH
Niyazi M
Pöttgen C
Rödel CM
Schatka I
Schwarzenboeck SM
Todica AS
Weber W
Wegen S
Wiegel T
Zamboglou C
Zips D
Zöphel K
Zschaeck S
Thorwarth D
Troost EGC
Source :: Nuklearmedizin. Nuclear medicine [Nuklearmedizin] 2021 Oct; Vol. 60 (5), pp. 326-343. Date of Electronic Publication: 2021 Jul 14.
Publication Year :: 2021
Abstract: This comprehensive review written by experts in their field gives an overview on the current status of incorporating positron emission tomography (PET) into radiation treatment planning. Moreover, it highlights ongoing studies for treatment individualisation and per-treatment tumour response monitoring for various primary tumours. Novel tracers and image analysis methods are discussed. The authors believe this contribution to be of crucial value for experts in the field as well as for policy makers deciding on the reimbursement of this powerful imaging modality.<br />Competing Interests: Wolfgang P. Fendler is a consultant for BTG, and he received fees from RadioMedix, Bayer, and Parexel outside of the submitted work.<br /> (Thieme. All rights reserved.)